Galux
PrivateLast Round
Series B
Feb 10, 2026
Total Funding Raised
$53.32M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Galux operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series B round in February 2026.
Galux is a biotechnology company that has developed an AI-powered drug design platform to identify and create novel therapeutics for a variety of diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Galux Comparables
Compare Galux with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nabla | 87% | |
| Genesis Molecular AI | 84% | |
| Scala Biodesign | 84% |
For institutional investors. Book with your work email.
Galux Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 10, 2026 | ||||
| VC Round | Oct 1, 2023 | ||||
| Series A | Oct 1, 2022 | ||||
| Seed | Dec 16, 2021 | ||||
| Pre Seed | Apr 1, 2021 |
For institutional investors. Book with your work email.
Galux Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InterVest | Series B, Seed, Series A, Pre Seed |
| SL Investment | Series B |
| DAYLI Partners | Series B |
| Pathway Capital Management | Series B, Series A |
| TKG Ventures | Series B |
| Mirae Asset Securities | Series B |
| NCORE Ventures | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 51% MoM, reaching 7.4K.
- Apr 16, 2026
Will attend and present at the AACR 2026 conference.
For institutional investors. Book with your work email.
Galux Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Galux's valuation, stock price, and market status.
Is Galux a public or private company?
Galux is a private company.
What is the current stock price of Galux?
Galux is a private company, so its shares have no public market price. Caplight tracks Galux's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Galux worth (valuation)?
Valuation information for Galux is not publicly available.
Can I buy Galux stock?
Galux shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Galux's last funding round?
Galux's most recent funding round was Series B on February 10, 2026.
Who are the main investors in Galux?
Key investors in Galux include InterVest, Yuanta Investment.
Will Galux IPO soon?
No public IPO plans have been announced for Galux.
How can I track Galux secondary market activity?
Caplight tracks bids, offers, and trades in Galux's shares on secondary markets.